Global Innovation – Lessons Learned from the Novo Nordisk Case

Global Innovation – Lessons Learned from the Novo Nordisk Case

This paper looks at the possibilities of Western multinationals to efficiently and effectively relocate research and development to emerging markets. In order to exemplify the findings, we will use the case of Danish pharmaceutical company Novo Nordisk and their approach to the Chinese market. Thus,...

Full description

Bibliographic Details
Main Authors: Nina BIRKMOSE, Ruxandra POPOVICI
Format: Article
Language:English
Published: Academy of Economic Studies (ASE) 2011-06-01
Series:European Journal of Interdisciplinary Studies
Subjects:
global strategy
foreign market entry
offshoring
R&D
pharmaceutics
Online Access:http://www.ejist.ro/files/pdf/339.pdf
id doaj-b65eeef1145143cfa39ca695cd3167a7
record_format Article
spelling doaj-b65eeef1145143cfa39ca695cd3167a72020-11-24T20:42:27ZengAcademy of Economic Studies (ASE)European Journal of Interdisciplinary Studies2067-37952011-06-01312130Global Innovation – Lessons Learned from the Novo Nordisk CaseNina BIRKMOSERuxandra POPOVICIThis paper looks at the possibilities of Western multinationals to efficiently and effectively relocate research and development to emerging markets. In order to exemplify the findings, we will use the case of Danish pharmaceutical company Novo Nordisk and their approach to the Chinese market. Thus, the research question of this paper is: Which lessons are to be learned from the case of Novo Nordisk in China?http://www.ejist.ro/files/pdf/339.pdfglobal strategyforeign market entryoffshoringR&Dpharmaceutics
collection DOAJ
language English
format Article
sources DOAJ
author Nina BIRKMOSE
Ruxandra POPOVICI
spellingShingle Nina BIRKMOSE
Ruxandra POPOVICI
Global Innovation – Lessons Learned from the Novo Nordisk Case
European Journal of Interdisciplinary Studies
global strategy
foreign market entry
offshoring
R&D
pharmaceutics
author_facet Nina BIRKMOSE
Ruxandra POPOVICI
author_sort Nina BIRKMOSE
title Global Innovation – Lessons Learned from the Novo Nordisk Case
title_short Global Innovation – Lessons Learned from the Novo Nordisk Case
title_full Global Innovation – Lessons Learned from the Novo Nordisk Case
title_fullStr Global Innovation – Lessons Learned from the Novo Nordisk Case
title_full_unstemmed Global Innovation – Lessons Learned from the Novo Nordisk Case
title_sort global innovation – lessons learned from the novo nordisk case
publisher Academy of Economic Studies (ASE)
series European Journal of Interdisciplinary Studies
issn 2067-3795
publishDate 2011-06-01
description This paper looks at the possibilities of Western multinationals to efficiently and effectively relocate research and development to emerging markets. In order to exemplify the findings, we will use the case of Danish pharmaceutical company Novo Nordisk and their approach to the Chinese market. Thus, the research question of this paper is: Which lessons are to be learned from the case of Novo Nordisk in China?
topic global strategy
foreign market entry
offshoring
R&D
pharmaceutics
url http://www.ejist.ro/files/pdf/339.pdf
work_keys_str_mv AT ninabirkmose globalinnovationlessonslearnedfromthenovonordiskcase
AT ruxandrapopovici globalinnovationlessonslearnedfromthenovonordiskcase
_version_ 1716822230442180608

Similar Items